
908 Devices Inc.
MASSNASDAQHealthcareMedical Devices
As of Nov 13, 2026 close
- Market cap
- $367.47M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.03$13.35
- Volume (live)
- -
- Avg. volume (3M)
- 387.81K
908 Devices (MASS) Stock Price & Financial Analysis
908 Devices Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.35 - $10.02 |
|---|---|
| 52-Week High | $13.35 |
| 52-Week Low | $5.03 |
| Open | $9.77 |
| Volume (last close) | 343.98K |
| Average Volume (3M) | 387.81K |
| Revenue (TTM) | 60.84M |
|---|---|
| Net Income (TTM) | −34.59M |
| Free Cash Flow (TTM) | 494.00K |
| EPS (TTM) | −$0.92 |
| Profit Margin | −56.85% |
| Operating Margin | −46.01% |
| Return on Equity (ROE) | −27.28% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 367.47M |
|---|---|
| Shares Outstanding | 37.73M |
| Price to Sales (P/S) | 6.04 |
| Price to Book (P/B) | 2.90 |
| EV/EBITDA | -8.29 |
| 50-Day MA | $11.17 |
|---|---|
| 200-Day MA | $8.56 |
| 1-Year Change | +77.74% |
Source: Market prices and company fundamentals. Data as of Nov 13, 2026. Data sources and methodology
908 Devices at a Glance
As of the Nov 13, 2026 close, 908 Devices (MASS) has a market capitalization of $367.47M. The stock trades at 6.0× sales. Over the trailing twelve months it lost $34.59M on revenue of $60.84M and generated $494.00K of free cash flow. Revenue grew 4.6% year over year.
As of its latest reported balance sheet, it holds $63.02M in cash and securities against $4.30M of debt, a net cash position of $58.72M.
908 Devices does not currently pay a dividend.
The share price is up 77.7% over the past year. At $9.74 (the Nov 13, 2026 close) it sits within its 52-week range of $5.03 to $13.35, above its 200-day moving average of $8.56.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.00, 43.7% above the Nov 13, 2026 close.
ETFs Holding MASS
Largest funds holding MASS, by assets
As of Oct 4, 2026, 908 Devices (MASS) is among the top 50 holdings of 2 US ETFs.
| ETF | Name | Weight | AUM | Expense Ratio |
|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 1.03% | $2.17B | 0.75% |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | 0.53% | $117.64M | 0.73% |
Source: ETF top holdings as reported by fund issuers (largest ~50 positions per fund). Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About 908 Devices
What is the current stock price for MASS?
As of the Nov 13, 2026 close, MASS stock trades at $9.74. The 52-week range is $5.03–$13.35, with a day range of $9.35–$10.02.
What is the P/E ratio for MASS?
908 Devices has no trailing P/E ratio because it reported a net loss over the last twelve months.
Does MASS pay dividends?
908 Devices does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MASS?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for MASS is Buy. The average 12-month price target is $14.00, a 43.7% upside from the Nov 13, 2026 close of $9.74.
What is the market cap of MASS?
As of the Nov 13, 2026 close, 908 Devices' market capitalization is $367.5M, classifying it as a small-cap company. 908 Devices operates in the Healthcare sector within the Medical Devices industry.